SASSINE ANDY — SEC Form 4 filings
SEC reporting owner CIK 1515322. 9 Form 4 filings on record with FilingPulse; latest filed 2025-08-20.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-17 to 2025-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 2,476 shares, $40,998 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 50,000 shares, $1,601,500 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 50,000 shares @ $32.03 ($1,601,500) in Arcturus Therapeutics Holdings Inc., filed 2024-06-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | Chief Financial Officer, Director | 4 | 2 legs · 2,476 sh · $40,998 | 1 leg · 50,000 sh · $1,601,500 | 1 |
| ICAD INC (ICAD) | Director | 5 | — | — | 22 |
Form 4 filings — SASSINE ANDY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-08-20 | 4/A | Arcturus Therapeutics Holdings Inc. (ARCT) | Purchase (P): 1,238 @ $16.56 | EDGAR |
| 2025-08-19 | 4 | Arcturus Therapeutics Holdings Inc. (ARCT) | Purchase (P): 1,238 @ $16.56 | EDGAR |
| 2025-07-17 | 4 | ICAD INC (ICAD) | Disposition to issuer (D): 1,198,382 · Disposition to issuer (D): 6,219 (derivative) · Disposition to issuer (D): 6,517 (derivative) · Disposition to issuer (D): 9,321 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 4,002 (derivative) · +12 more | EDGAR |
| 2025-01-07 | 4 | ICAD INC (ICAD) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | ICAD INC (ICAD) | Grant/award (A): 27,586 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale (S): 50,000 @ $32.03 | EDGAR |
| 2024-04-03 | 4 | ICAD INC (ICAD) | Grant/award (A): 25,259 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | ICAD INC (ICAD) | Grant/award (A): 30,265 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1515322 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →